Symbol
RNA on Nasdaq
Investment type
Equity / Common Stock
Latest Disclosed Shares Owned
4,686,110 shares
Security Ownership %
3.1%
Shares, Excluding Options vs Price
Value, Excluding Options

RTW Investments, LP ownership in Atrium Therapeutics, Inc. Common Stock (RNA)

29 Oct 2025 - RTW Investments, LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,686,110 shares of Atrium Therapeutics, Inc. Common Stock (RNA). This represents 3.1% ownership of the company. This is the first filing by RTW INVESTMENTS, LP disclosing ownership of Atrium Therapeutics, Inc. Common Stock (RNA).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.